Results per Page:
How effective is elranatamab for treating multiple myeloma in the real world?
From Dr. Andrew Portuguese, Clinical Research Division
Extramedullary disease shapes toxicity risk in BCMA CAR T therapy
From the Gauthier Group, Clinical Research Division
A tale of two T-cells: comparing liso-cel and axi-cel for treatment of refractory large B-cell lymphoma
From the Gauthier group, Clinical Research Division